BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6173346)

  • 1. Plasminogen activator (urokinase) causes vascularization of the cornea.
    Berman M; Winthrop S; Ausprunk D; Rose J; Langer R; Gage J
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):191-9. PubMed ID: 6173346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration.
    Berman M; Leary R; Gage J
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1204-21. PubMed ID: 6252112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal vascularization prevents corneal ulceration.
    Conn H; Berman M; Kenyon K; Langer R; Gage J
    Invest Ophthalmol Vis Sci; 1980 Apr; 19(4):362-70. PubMed ID: 6153640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the fibrinolytic system in corneal angiogenesis.
    Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
    Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of angiogenesis in the cornea with amiloride].
    Ignjatović Z; Nikolić Lj
    Srp Arh Celok Lek; 1996; 124(5-6):120-3. PubMed ID: 9102830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent and active plasminogen activator in corneal ulceration.
    Wang HM; Berman M; Law M
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):511-24. PubMed ID: 2984139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulceration is correlated with degradation of fibrin and fibronectin at the corneal surface.
    Berman M; Manseau E; Law M; Aiken D
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1358-66. PubMed ID: 6225746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice.
    Ren CJ; Ueda F; Roses DF; Harris MN; Mignatti P; Rifkin DB; Shapiro RL
    J Surg Res; 1998 Jul; 77(2):126-31. PubMed ID: 9733598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration.
    Morimoto K; Mishima H; Nishida T; Otori T
    Thromb Haemost; 1993 Apr; 69(4):387-91. PubMed ID: 8497852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
    Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhibition of urokinase-type plasminogen activator (u-PA) by amiloride in the cornea and tear fluid of eyes irradiated with UVB.
    Cejková J; Cejka C; Zvárová J
    Acta Histochem; 2005; 107(1):77-86. PubMed ID: 15866288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolysis components and angiogenesis regulation by example of burn-induced corneal neovascularization in rabbits].
    Chesnokova NB; Aĭsina RB; Mukhametova LI; Pavlenko TA; Gulin DA; Beznos OV
    Vestn Oftalmol; 2012; 128(4):62-5. PubMed ID: 22994111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium.
    Tao Y; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2037-46. PubMed ID: 8814143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical amiloride accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits.
    Sood AK; Gupta B; Chugh P
    Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):491-7. PubMed ID: 10544394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of viscoelastics on cultured corneal epithelial cells measured by plasminogen activator release.
    Lindquist TD; Edenfield M
    J Refract Corneal Surg; 1994; 10(2):95-102. PubMed ID: 7517294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis.
    Conrad TJ; Chandler DB; Corless JM; Klintworth GK
    Lab Invest; 1994 Mar; 70(3):426-34. PubMed ID: 7511717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of corneal fibroblast MMP-1 collagenase secretion by plasmin.
    Berman MB
    Cornea; 1993 Sep; 12(5):420-32. PubMed ID: 8306664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G; Bjornsson TD; Vlodavsky I
    J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.